BMS specializes in the design and manufacturing of medical textiles with expertise in knitting, braiding, weaving and non-woven technology. The company utilizes a wide variety of implantable-grade absorbable and non-absorbable biomaterials in orthopedic, general surgery, tissue engineering, cardiovascular, bariatric, cosmetic surgery and veterinary applications, including implantable devices and drug delivery technologies.
Concordia will retain an ownership stake in BMS. Concordia President and CEO Randal Spencer will join the BMS board of directors and continue to assist the business development of the combined operation.
Read the company news release about BMS acquiring Concordia.
Read other coverage about medical device acquisitions:
– Hanger Orthopedic Group Completes Acquisition of Accelerated Care Plus
– Zimmer Finalizes Acquisition of Beijing Montagne Medical Device Co.
– Stryker Acquires Gaymar Industries for $150M
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
